Join us for two engaging days of discussion and networking at Boston CEO as Longwood Healthcare Leaders brings together top thought leaders across pharma, biotech, government, academia, healthcare, and investing. This not-to-be missed forum brings the right executives together, all in one room, at the Mandarin Oriental Boston, October 28-29. Don’t miss your chance to be part of this important gathering.

Cocktail Reception 

Meeting participants will enjoy a lively cocktail reception immediately following the final sessions, October 29, 5 pm.

Boston CEO Agenda

Monday October 28, 2024

7:00 am 

REGISTRATION & NETWORKING BREAKFAST

7:30 am

LONGWOOD FUND INTRODUCTION

Vikas Goyal, Venture Partner, Longwood Fund

8:00 am

ACCELERATING THE TRANSLATION OF SCIENCE INTO MEDICINE

Sandra Glucksmann, CEO, Sensorium Therapeutics

Theresa Heah, CEO, Paratus Sciences

Sek Kathiresan, CEO, Verve Therapeutics

Mathai Mammen, CEO, FogPharma

Moderator: John Lepore, CEO, ProFound Therapeutics

8:30 am 

R&D COLLABORATION

Susan Hockfield, President Emerita, MIT

Anne Klibanski, CEO, Mass General Brigham

Trevor Martin, CEO, Mammoth Biosciences

Kendra Rose, SVP & Head, BD&L New Platforms, Bayer Pharmaceuticals 

Moderator: Aaron Mitchell, Managing Partner, ZS Associates

9:00 am

REGULATORY & INDUSTRY ROUNDTABLE

Ted Love, Chair, BIO

Peter Marks, Director, CBER, FDA

Moderator: Christoph Westphal, General Partner, Longwood Fund

9:20 am 

FIRESIDE CHAT

Ed Markey, Senator, Commonwealth of Massachusetts

Moderator: Christoph Westphal, General Partner, Longwood Fund

9:40 am 

NETWORKING BREAK

10:10 am 

COMPANY FORMATION: BUILDING A BIOTECH

Marion Dorsch, CSO, Atavistik Bio

Dipal Doshi, CEO, Entrada Therapeutics

Chris Loose, CEO, Progentos Therapeutics

Wendye Robbins, CEO, Incendia Therapeutics

Moderator: Caroline Loew, CEO, Mural Oncology

10:40 am 

INNOVATION IN CLINICAL TRIALS

Brian Alexander, SVP, Pharma R&D, Roche Genentech

Camille Bedrosian, CMO, Amylyx Pharmaceuticals

Ed Kaye, CEO, Stoke Therapeutics

Gilmore O’Neill, CEO, Editas

Moderator: Jim Anthony, President, Parexel Biotech

11:10 am 

EXPANDING PLATFORM POTENTIAL

Michael Amoroso, CEO, Precision Biosciences 

Rachel Humphrey, CEO, Normunity

Cigall Kadoch, Assoc. Professor, Dana-Farber Cancer Institute & Harvard Medical School

Victoria Richon, CEO, Entact Bio

Zhen Su, CEO, Marengo Therapeutics

Moderator: Mike Jahner, VP, Life Sciences, Alliant

11:40 am 

GUBERNATORIAL KEYNOTE

Maura Healey, Governor, Commonwealth of Massachusetts

Moderator: Christoph Westphal, General Partner, Longwood Fund

12:00 pm 

NETWORKING LUNCHEON

1:00 pm 

INNOVATION IN CELL THERAPY

Sharon Benzeno, CCO, Adaptive Biotechnologies

Maurits Geerlings, CEO, NanoCell Therapeutics

Paul Lammers, Board Director, Diakonos Oncology

Raj Prasad, CFO, CRISPR Therapeutics

Moderator: Greg Licholai, Chief Medical & Innovation Officer, ICON

1:30 pm 

PREPARING FOR COMMERCIAL DEPLOYMENT

Shalabh Gupta, CEO, Unicycive Therapeutics

Rachid Izzar, EVP, Head, Global Product Strategy & Commercialization, Biogen

Vikram Karnani, EVP, Global Commercial & Medical Affairs, Rare Disease, Amgen

Deniz Razon, CBO, Servier Pharmaceuticals

Moderator: Leslie Orne, CEO, Trinity Partners

2:00 pm 

POLICY IMPACT ON INNOVATION

Kendalle Burlin O’Connell, CEO, MassBio

Priya Singhal, EVP, Head, Development, Biogen

Skip Virgin, Distinguished Fellow, AI Drug Discovery & Development, Gates Foundation

Moderator: Louis Fogel, Principal, Fish & Richardson

2:30 pm 

SPOTLIGHT ON BIOMEDICAL INNOVATION

Paola Arlotta, Chair, Stem Cell & Regenerative Biology, Harvard University

Lew Cantley, Professor, Cell Biology, Harvard Medical School

Samir Hanash, Director, Institute for Cancer Detection and Treatment, MD Anderson Cancer Center

Andrew Lane, Associate Chief, Hematologic Neoplasia, Dana-Farber Cancer Institute

Moderator: Lizzie Ngo, Principal, Longwood Fund

2:50 pm 

NETWORKING BREAK

3:20 pm 

IMPROVING HEALTH EQUITY AND PATIENT IMPACT

Anna Kazanchyan, CEO, Sanghmos Therapeutics

Gavin MacBeath, CEO, TScan Therapeutics

Deborah Mash, CEO, DemeRx

Ramona Sequeira, President, Global Portfolio, Takeda

Moderator: Sharon Suchotliff, Associate Partner, ZS Associates

3:50 pm 

FIRESIDE CHAT

Mary Lynne Hedley, Co-Founder, President & COO, TESARO

John Maraganore, former CEO, Alnylam

Moderator: Kailash Swarna, Managing Director, Accenture

4:10 pm 

ALIGNING PRIORITIES FOR THE PARTNERSHIP

Vanessa Almendro-Navarro, VP, Head of Innovation, Danaher

Paul Biondi, President, Pioneering Medicines

Evan Lippman, Chief Corporate Development & Strategy Officer, Alnylam

Dominique Verhelle, CEO, NextRNA

Moderator: Richard Paulson, CEO, Karyopharm Therapeutics

4:40 pm 

STRUCTURING THE SYNDICATE

Miles Gerson, Global Head, Takeda Ventures

Tony Ho, Chief Scientific Officer & Senior Science Partner, Pivotal

Omar Khalil, Managing Director, Santé Ventures

Campbell Murray, Senior Partner, Bioluminescence Ventures

Moderator: Lucy Liu, Principal, Longwood Fund

Tuesday October 29, 2024

7:00 am 

REGISTRATION & NETWORKING BREAKFAST

7:30 am 

LONGWOOD FUND INTRODUCTION

Aleks Radovic-Moreno, Partner, Longwood Fund

8:00 am 

PHARMA PIPELINE SOURCING

Fawzi Benzaghou, SVP, Global Head, Oncology, Ipsen

Kathy Fernando, SVP, Global Head, Pfizer Ignite

Pallavi Garg, Head, US Oncology Business Unit, Takeda 

John Pottage, Lead Scientific Consultant, INTREPID Alliance

Moderator: Michelle Longmire, CEO, Medable

8:30 am 

TARGETING GLP-1

Jørgen Petersen, Senior Partner, Novo Holdings

Raymond Stevens, CEO, Structure Therapeutics

Moderator: Kyle Lefkoff, General Partner, Boulder Ventures

8:50 am 

LEVERAGING TECHNOLOGY TO ADVANCE THE PIPELINE

Jason Cole, CEO, SalioGen Therapeutics

Hanadie Yousef, CEO, Juvena Therapeutics

Kai Wucherpfennig, Chair, Cancer Immunology & Virology, Dana-Farber Cancer Institute

Ashley Zehnder, CEO, Fauna Bio

Moderator: Chandra Ramanathan, Head, External Innovation, Danaher

9:20 am 

ACCELERATING DRUG DISCOVERY

Daniel Dornbusch, CEO, Excision BioTherapeutics

Frank Haluska, CEO, Kestrel Therapeutics

Jennifer Michaelson, CSO, Cullinan Therapeutics

Brian Safina, CEO, Magnet Biomedicine

Moderator: Harvey Berger, CEO, Kojin Therapeutics

9:50 am 

NETWORKING BREAK 

10:20 am 

TARGETED MERGERS & ACQUSITIONS

Jeff Capello, former CFO, Biogen

Jessica Chutter, Managing Director, Chair, Biotechnology Investment Banking, Morgan Stanley

Raj Khunkhun, Head, Neuroscience BD, Takeda

Chris Sheldon, SVP, Global Head, BD, GSK

Moderator: Philippe Lopes-Fernandes, CBO, Ipsen

10:50 am 

ALIGNING WITH REGULATORY AUTHORITIES

Jessica Ballinger, CEO, Lyndra Therapeutics

Ned Braunstein, EVP, Regulatory Affairs & Global Patient Safety, Regeneron

Peter Hutt, General Counsel (former), FDA

Thomas Lonngren, Executive Director (former), EMA

Moderator: DA Gros, CEO, Eledon Therapeutics

11:20 am 

PATIENT-CENTRIC DEVELOPMENT

Craig Bunnell, CMO, Dana-Farber Cancer Institute

Caroline Kant, CEO, EspeRare Foundation

Sarah Sheikh, Head, Global Development & SVP, Neuroscience, Takeda

Brandon Turunen, CTO, Solu Therapeutics

Moderator: Ariel Katz, CEO, H1

11:50 am 

FIRESIDE CHAT

Levi Garraway, CMO, Genentech

Robert Plenge, Chief Research Officer, Head of Research, BMS

George Yancopoulos, President & CSO, Regeneron

Bob Weinberg, Founding Member, Whitehead Institute, MIT 

Moderator: Christoph Westphal, General Partner, Longwood Fund

12:20 pm 

NETWORKING LUNCHEON

12:50 pm 

DRIVING PRODUCTIVITY IN R&D

Johanna Bendell, Global Head, Oncology, pRED, Roche

Gina Consylman, R&D, CFO & COO, Takeda

Nello Mainolfi, CEO, Kymera

Joanna Stanicka, CEO, Axonis

Moderator: Yiannis Kiachopoulos, CEO, Causaly

1:20 pm 

FIRESIDE CHAT

Alan Garber, President, Harvard University

Sally Kornbluth, President, MIT

Moderator: Christoph Westphal, General Partner, Longwood Fund

1:50 pm 

IDENTIFYING NEXT GENERATION THERAPEUTICS

Rosana Kapeller, CEO, Rome Therapeutics

Mark Rus, CEO, Delix Therapeutics

Oliver Rosen, CMO, Akamis Bio

Paul Peter Tak, CEO, Candel Therapeutics

Moderator: Brian Taylor, CEO, SmartLabs

2:20 pm 

DEVELOPING AN EFFECTIVE BOARD

Nenad Grmusa, CEO, Dem BioPharma

Tamar Thompson, Head, Global Corporate Affairs, Alexion

Leslie Williams, CEO, hC Bioscience

Moderator: Luba Greenwood, Managing Director, Binney Street Capital, Dana-Farber Cancer Institute

2:50 pm 

NETWORKING BREAK

3:20 pm

FIRESIDE CHAT: PHARMA R&D

Fiona Marshall, President, Biomedical Research, Novartis

Marcus Schindler, CSO & EVP, Research & Early Development, Novo Nordisk

Moderator: Kailash Swarna, Managing Director, Accenture



3:40 pm

BIOMANUFACTURING: PLANNING FOR FUTURE SUCCESS 

Al Gianchetti, CEO, XyloCor 

Marinna Madrid, Chief Product Officer, CellinoBio

Hari Pujar, COO, Tessera Therapeutics

Moderator: Andrew Obenshain, CEO, bluebird bio

4:10 pm

THE EVOLVING DEAL-MAKING LANDSCAPE

Jie D’Elia, CEO, SystImmune

Amanda Kay, Senior Partner & Chief BD Officer, Flagship Pioneering

Debra Peattie, Managing Partner, SV Investment

Stu Mackey, Global Head, BD, Daiichi Sankyo

Moderator: Bob Silverman, CBO, Turbine

4:40 pm

INVESTOR PERSPECTIVES IN ELECTION SEASON

Dean Dimizas, Managing Director, Cambridge Associates

Ansbert Gadicke, Managing Partner, MPM BioImpact

Claudine Prowse, Venture Partner, JP Morgan Asset Management

Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund

5:00 pm 

COCKTAIL RECEPTION

Upcoming Events

Supporters 

To learn more about getting involved, contact sg@longwoodfund.com

#LongwoodHealthcareLeaders